Millipore Says It is Bullish on Continuous Bioprocessing

GEN Podcasts

English - September 26, 2017 17:42 - 11 minutes - 5.57 MB - ★★★★★ - 4 ratings
Technology biotech biotechnology bioprocessing cell and gene therapy drug discovery gene editing genomics molecular biology cancer research next gen sequencing Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: New Drug Delivery Materials May Help Patient Compliance with Meds

Next Episode: New Method Developed for Growing Tissue Engineered Corneas

GEN Sounds of Science September 15, 2017MilliporeSigma is using is expertise in biomanufacturing to take advantage of the growing interest in continuous or next generation bioprocessing. The company is investing in specific technologies in terms of dedicated teams, focused R&D efforts, and product-development projects.Website: http://www.emdmillipore.com/

Hosted on Acast. See acast.com/privacy for more information.